Herschorn, Sender, Jameel Nazir, Barbara Ramos, and Zalmai Hakimi. “Supplementary Data: Cost-Effectiveness of Mirabegron Compared to Tolterodine ER 4 Mg for Overactive Bladder in Canada”. Canadian Urological Association Journal 11, no. 3-4 (April 11, 2017): E129–33. Accessed May 2, 2024. https://cuaj.ca/index.php/journal/article/view/4617.